Patient Portal

Salim Chahin, MD, MSCE

Assistant Professor, Neurology 

Specialty Areas

Multiple Sclerosis

Board Certifications


Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Multiple sclerosis, neuromyelitis optica, neuroimmunology

  • Location(s)
  • Education
  • Publication & Research
  • Financial Disclosures



Barnes-Jewish Hospital
McMillan Building

517 S. Euclid Avenue
St. Louis, MO 63110

Office Phone: 314-362-3293
Fax: 314-747-1345



Fellowship: Multiple Sclerosis, University of Pennsylvania, Philadelphia Pennsylvania 2015
Residency: Neurology, University of Iowa, Iowa City, Iowa 2011
MSCE: University of Pennsylvania, Philadelphia, Pennsylvania 2014
Medical Degree: Damascus University School of Medicine, Damascus, Syria 2004

Publication & Research

Publication & Research

Koelman DL, Benkeser DC, Xu Y, Neo SX, Tan K, Katsuno M, Sobue G, Natsume J, Chahin S, Mar SS, Venkatesan A, Chitnis T, Hoganson GM, Yeshokumar AK, Barreras P, Majmudar B, Carone M, Mateen FJ. Acute disseminated encephalomyelitis in China, Singapore and Japan: a comparison with the USA. Eur J Neurol. 2017 Feb;24(2):391-396. doi: 10.1111/ene.13220. PubMed PMID: 28009079


Waldman AT, Chahin S, Lavery AM, Liu G, Banwell BL, Liu GT, Balcer LJ. Binocular low-contrast letter acuity and the symbol digit modalities test improve the ability of the Multiple Sclerosis Functional Composite to predict disease in pediatric multiple sclerosis. Mult Scler Relat Disord. 2016 Nov;10:73-78. doi: 10.1016/j.msard.2016.08.012. PubMed PMID: 27919503; PubMed Central PMCID: PMC5144918.


Dworkin JD, Sweeney EM, Schindler MK, Chahin S, Reich DS, Shinohara RT. PREVAIL: Predicting Recovery through Estimation and Visualization of Active and Incident Lesions. Neuroimage Clin. 2016 Aug 2;12:293-9. doi: 10.1016/j.nicl.2016.07.015. PubMed PMID: 27551666; PubMed Central PMCID: PMC4983640.


Koelman DL, Chahin S, Mar SS, Venkatesan A, Hoganson GM, Yeshokumar AK, Barreras P, Majmudar B, Klein JP, Chitnis T, Benkeser DC, Carone M, Mateen FJ. Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study. Neurology. 2016 May 31;86(22):2085-93. doi: 10.1212/WNL.0000000000002723. PubMed PMID: 27164698.


Williamson EM, Chahin S, Berger JR. Vaccines in Multiple Sclerosis. Curr Neurol Neurosci Rep. 2016 Apr;16(4):36. doi: 10.1007/s11910-016-0637-6. Review. PubMed PMID: 26922172.


Chahin S, Weber T, Berger, JR. Progressive Multifocal Leukoencephalopathies. International Neurology, 2nd edition. April 2016


Chahin S, Miller D, Sakai RE, Wilson JA, Frohman T, Markowitz C, Jacobs D, Green A, Calabresi PA, Frohman EM, Galetta SL, Balcer LJ. Relation of

quantitative visual and neurologic outcomes to fatigue in multiple sclerosis. Mult Scler Relat Disord. 2015 Jul;4(4):304-10. doi: 10.1016/j.msard.2015.05.005. PubMed PMID: 26195047.


Chahin S, Berger JR. A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy. J Neurovirol. 2015 Dec;21(6):623-31. doi: 10.1007/s13365-014-0303-1. PubMed PMID: 25404234.


Chahin S, Balcer LJ, Miller DM, Zhang A, Galetta SL. Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of

life. J Neuroophthalmol. 2015 Mar;35(1):6-11. doi: 10.1097/WNO.0000000000000173. PubMed PMID: 25370598; PubMed Central PMCID: PMC4337583.


 Chahin S, Garwood MD, St Louis EK, Shivapour ET, Kelkar PM, Granner MA. Intramedullary Sjögren syndrome. Neurology. 2009 Dec 8;73(23):2041-2. doi:10.1212/WNL.0b013e3181c55ced. PubMed PMID: 19996081; PubMed Central PMCID: PMC2796455.


Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2018:

Company Name: Sanofi Genzyme


Equity: No

Consulting/Advisory Board: $1 - $9,999

Speaker Fees: $10,000 - $19,999

Reporting Date: May 01, 2019

Areas of Research Interest

Exploring novel outcome measures and biomarkers for multiple sclerosis and other demyelinating diseases